Mercy Health Research

St Louis, Missouri 63141

0 studies enrolling now · 52 studies all time

What they study most

Acute Treatment of Migraine, Analgesia, Arthritis, Attention Deficit Disorders With Hyperactivity, Attention Deficit Hyperactivity Disorder, Attention Deficit Hyperactivity Disorders, Autism, Autistic Disorder, Child Development Disorders, Pervasive, Chronic Cluster Headache, Chronic Low Back Pain, Chronic Migraine

Studies at this site

Evaluation of Treatment Satisfaction and Preference for Sumavel DosePro in the Treatment of Migraine — Completed
Erenumab - Comprehensive Assessment of Efficacy in (High-Frequency) Episodic Migraine — Completed
Study of Sustained Benefit of AMG334 in Adult Episodic Migraine Patients — Completed
Dose Ranging Study of Rimegepant (BMS-927711) for the Acute Treatment of Migraine — Completed
Long-Term Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Pain — Completed
Study Evaluated the Effectiveness of Milnacipran to Reduce Pain Levels in Individuals With Chronic Migraine — Completed
A Study of Tanezumab in Adults With Chronic Low Back Pain — Completed
SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study — Stopped early
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder — Completed
Tanezumab In Osteoarthritis Of The Hip Or Knee — Stopped early
Tanezumab In Osteoarthritis Of The Knee (2) — Completed
Extension Study Of Tanezumab In Osteoarthritis — Stopped early
Long Term Safety Study of Tanezumab in Chronic Low Back Pain — Stopped early
Tanezumab in Osteoarthritis of the Knee — Completed
Tanezumab in Osteoarthritis Of The Hip — Completed
Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain — Completed
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients — Completed
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy — Completed
Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder (MDD) — Completed
A Safety Study of Galcanezumab in Participants With Migraine, With or Without Aura — Completed
Efficacy and Safety of Hydrocodone Bitartrate (HYD) in Subjects With Moderate to Severe Chronic Low Back Pain — Completed
Long-term Safety of Once-daily Hydrocodone Bitartrate (HYD) Tablets For Moderate to Severe Chronic Nonmalignant and Nonneuropathic Pain. Includes a 24-week Extension Period. — Completed
CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes — Completed
A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM) — Stopped early
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome — Completed
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age — Completed
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17 — Completed
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache — Completed
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache — Status unconfirmed
Efficacy and Safety Study of BOTOX® Compared to Topiramate for the Prevention of Chronic Migraine in Adults — Completed
Efficacy and Safety of 20 mg Sumatriptan Powder Delivered Intranasally With the Bi-directional Device Compared With 100 mg Sumatriptan Tablets in Adults With Acute Migraine With or Without Aura — Completed
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain — Completed
A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine — Completed
Study To Evaluate Cardiac Assessments Following Different Treatments Of Smoking Cessation Medications In Subjects With And Without Psychiatric Disorders. — Completed
Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders — Completed
Safety and Efficacy of Saxagliptin in Triple Therapy to Treat Subjects With Type 2 Diabetes — Completed
Diabetic Peripheral Neuropathic Pain (DPNP) — Completed
Efficacy and Safety of Oxycodone/Naloxone Controlled-release Tablets (OXN) Compared to Placebo in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain — Completed
Safety & Efficacy of a Single Dose of Sumatriptan Powder Delivered Intranasally With the Bi-directional Device in Adults With Acute Migraine — Completed
A 2-Month Safety Follow-Up Trial — Completed
A Safety and Efficacy Study Comparing Naltrexone SR/Bupropion SR and Placebo in Obese Subjects With Type 2 Diabetes — Completed
A Safety and Efficacy Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects — Completed
Safety of Inhaled Insulin With Type 1 and Type 2 Diabetes — Completed
Study of NXN 188 for the Treatment of Migraine With Aura — Completed
A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine — Completed
Zonisamide SR Plus Bupropion SR Combination Therapy in Subjects With Obesity — Completed
Efficacy and Safety of TMS for the Preemptive Treatment of Migraine With Aura — Completed
Study to Assess the Safety and Efficacy of NRP104 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD) — Completed
A Study of Rizatriptan Co-Administered With Acetaminophen for the Treatment of Acute Migraine — Completed
An Efficacy Study of a Single Dose Treatment of PRO-513 for Subjects Suffering a Migraine Attack — Completed